# EDGAR Filing Document

**Accession Number:** 0001909617
**File Stem:** 0001104659-25-086380
**Filing Date:** 2025-9
**Character Count:** 5023
**Document Hash:** f96d777e65cccc50689f27dac594c00d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-086380.hdr.sgml**: 20250902

**ACCESSION NUMBER**: 0001104659-25-086380

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250902

**EFFECTIVENESS DATE**: 20250902

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Qiming U.S. Ventures Management, LLC
- **CENTRAL INDEX KEY:** 0001909617

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-22101
- **FILM NUMBER:** 251285702

**BUSINESS ADDRESS:**
- **STREET 1:** 11100 NE 8TH ST., SUITE 200
- **CITY:** BELLEVUE
- **STATE:** WA
- **ZIP:** 98004
- **BUSINESS PHONE:** (425) 709-0772

**MAIL ADDRESS:**
- **STREET 1:** 11100 NE 8TH ST., SUITE 200
- **CITY:** BELLEVUE
- **STATE:** WA
- **ZIP:** 98004

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001909617

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Qiming U.S. Ventures Management, LLC

**Address:** 11100 NE 8th St., Suite 200, Bellevue, WA 98004

**Telephone number:** 425-709-0772

**Name of agent for service:** Ryan Baker

**Agent Address:** c/o Qiming U.S. Ventures Management, LLC, Bellevue, WA 98004

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-22101

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER            | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                             | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| Kezar Life Sciences, Inc. | 49372L209 | 06/17/2025     | Advisory vote on the compensation paid to our named executive officers.                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |          82871 |                0 | FOR         |                                    82871 | FOR                         |  |
| Korro Bio, Inc.           | 500946108 | 06/11/2025     | Non-Binding Advisory Vote to Approve the Compensation of our Named Executive Officers.                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |         368085 |                0 | FOR         |                                   368085 | FOR                         |  |
| Korro Bio, Inc.           | 500946108 | 06/11/2025     | Non-Binding Advisory Vote on the Frequency of Future Non-Bindig Advisory Votes to Approve the Compensation of our Named Executive Officers                                                                                   | SECTION 14A SAY-ON-PAY VOTES |         368085 |                0 | 1 YR        |                                   368085 | FOR                         |  |
| Ventyx Biosciences Inc.   | 92332V107 | 06/04/2025     | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement (the "Say-on-Pay Vote"). | SECTION 14A SAY-ON-PAY VOTES |         412225 |                0 | FOR         |                                   412225 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** Qiming U.S. Ventures Management, LLC

**By (Signature):** Ryan Baker

**By (Printed Signature):** Ryan Baker

**By (Title):** Chief Financial Officer

**Date:** 09/02/2025